AZD2373
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for AZD2373, covering 2025-10-29 to 2025-10-29. Get the full timeline:
Most recent: Clinical Trial Update: Dose-Ranging Safety, Tolerability, and Efficacy Study of AZD2373 in Participants With APOL1-Mediated Kidney Disease [Phase 2]